Ultram® (tramadol) Containing Products Added as Scheduled IV Controlled Substances in North Dakota
Governor Dalrymple signed into law House Bill 1070 which with the emergency clause makes this bill effective immediately. This bill adds tramadol and tramadol containing products as schedule IV substances.
Processing prescriptions for tramadol will now fall under the same state law requirements as other controlled substances. It is important to communicate this with the practitioners and patients whose prescriptions may be effected by the law change to ensure a smooth transition for all involved.
North Dakota pharmacies must take and file an initial inventory level of these products and ensure they are inventoried upon their scheduled biennial inventory.
Public Rule Hearing Scheduled for the North Dakota Pharmacists Association Convention
- Full Notice 4-5-2014 Hearing (72 KB PDF)
- 61-02-01-01 Class L Pharmacy Permit (149 KB PDF)
- 61-02-01-18 Continuous Quality Improvement and 61-02-01-19 Policy & Procedure (155 KB PDF)
- 61-11 Fees from SB 2342 (69 KB PDF)
- 61-04-02 Physician Exemption Revision (98 KB PDF)
- 61-04-08-07 Collaborative Agreement Signature Page (20 KB PDF)
- 61-08 Inspection Rule for Out of State Pharmacies (77 KB PDF)
- 61-12 ASAP Version for Reporting to PDMP (64 KB PDF)
- 61-12 Use Requirements for Pharmacies to Access the PDMP (65 KB PDF)
- Regulatory Analysis for Above Rules (90 KB PDF)
- Fiscal Note for Above Rules (257 KB PDF)
Durable Medical Equipment Licensure for North Dakota Required by August 1, 2013
Durable Medical Equipment Licensure for North Dakota Required by August 1, 2013 - click here for details.
Click here for SB 2342 which includes the licensing requirements.
Obtaining a NPLEx Account
If your pharmacy sells ephedrine and/or pseudoephedrine over the counter, you will need to request access to the National Precursor Log Exchange (NPLEx) by visiting www.NPLExSurvey.com. Please click on the appropriate state and complete the survey for an NPLEx account. Once your account has been verified, you will be contacted by Appriss, provider of NPLEx, to inform you of next steps.
DEA Issues Statement on Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies
The Drug Enforcement Administration (DEA) has issued a statement of policy to provide guidance under existing law regarding the proper role of a duly authorized agent of a DEA-registered individual practitioner in connection with the communication of a controlled substance prescription to a pharmacy.
For more information and a sample of the Designated Agent to Communicate Controlled Substance Prescriptions to Pharmacies form, please click here.
NDSU CE Survey
Help NDSU determine what CE programs you would like. Please click here to fill out the survey.
Pharmacy in North Dakota exists as a force in society for the safe, rational, and cost effective use of pharmaceuticals and medical devices. Through the provision of pharmaceutical care, the profession is responsible for the appropriate use of medications and devices to achieve optimal therapeutic outcomes. The profession endeavors to enhance the pharmacist’s ability to provide pharmaceutical care as a primary health care provider and to further the public recognition of the profession value.
Pharmacy is a service profession. The philosophy of pharmaceutical care focuses on the patient as the beneficiary of pharmacists’ activities. The responsible provision of pharmaceutical therapy for the purpose of achieving definite outcomes is intended to improve patient’s quality of life.
Our profession acknowledges and pursues the highest ethical standards in all endeavors. Honesty and integrity guide all interactions with patients, other healthcare practitioners, and the general public.
Our profession requires that pharmacists possess the knowledge and skills to practice pharmacy as contemporarily defined.
A profession that is recognized as primary healthcare provider capable of responding to society’s healthcare needs.